On Monday, Jade Biosciences Inc (NASDAQ: JBIO) was 17.66% up from the session before settling in for the closing price of $10.7. A 52-week range for JBIO has been $6.57 – $13.50.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -77.98%. When this article was written, the company’s average yearly earnings per share was at 95.86%. With a float of $24.29 million, this company’s outstanding shares have now reached $32.63 million.
Jade Biosciences Inc (JBIO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Jade Biosciences Inc stocks. The insider ownership of Jade Biosciences Inc is 25.57%, while institutional ownership is 83.64%. The most recent insider transaction that took place on Jun 25 ’25, was worth 303,679. Before that another transaction happened on Jun 25 ’25, when Company’s Shareholder proposed sale 235 for $10.48, making the entire transaction worth $2,463.
Jade Biosciences Inc (JBIO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 95.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 66.72% during the next five years compared to -77.98% drop over the previous five years of trading.
Jade Biosciences Inc (NASDAQ: JBIO) Trading Performance Indicators
You can see what Jade Biosciences Inc (JBIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.36, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.94 in one year’s time.
Technical Analysis of Jade Biosciences Inc (JBIO)
Compared to the last year’s volume of 0.16 million, its volume of 0.31 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 79.65%.
During the past 100 days, Jade Biosciences Inc’s (JBIO) raw stochastic average was set at 85.80%, which indicates a significant increase from 81.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.95 in the past 14 days, which was higher than the 0.71 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.01, while its 200-day Moving Average is $32.14. Nevertheless, the first resistance level for the watch stands at $13.78 in the near term. At $14.97, the stock is likely to face the second major resistance level. The third major resistance level sits at $16.38. If the price goes on to break the first support level at $11.19, it is likely to go to the next support level at $9.78. Now, if the price goes above the second support level, the third support stands at $8.59.
Jade Biosciences Inc (NASDAQ: JBIO) Key Stats
There are 32,627K outstanding shares of the company, which has a market capitalization of 410.78 million. As of now, sales total 0 K while income totals -69,630 K. Its latest quarter income was 0 K while its last quarter net income were -32,130 K.
